Loading
A phase 3 trial of Flutamide and Triptorelin in Prostate cancer, run by UNICANCER, completed.
Triptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer is a phase 3 interventional study registered as NCT00104741 by UNICANCER, with 378 participants recorded, started 2003-09-10 and reaching its primary completion in 2015-10. Interventions recorded: flutamide, triptorelin, radiation therapy. Conditions recorded: Prostate Cancer.
Linked to the drug Flutamide because the registry names it among its interventions and Prostate cancer among its conditions. Registry record only: no result has been read by an editor.
Shares Triptorelin, Prostate cancer and the tag pipeline.
Shares Flutamide, Triptorelin, Prostate cancer and the tag pipeline.
Shares Flutamide, Prostate cancer and the tag pipeline.
Shares Flutamide, Triptorelin, Prostate cancer and the tag pipeline.
Shares Flutamide, Triptorelin, Prostate cancer and the tag pipeline.
Shares Flutamide, Triptorelin, Prostate cancer and the tag pipeline.
Shares Flutamide, Prostate cancer and the tag pipeline.
Shares Triptorelin and the tag pipeline.